Core Insights - Nyxoah SA reported a quarterly loss of $0.74 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.61, and compared to a loss of $0.55 per share a year ago, indicating a significant earnings surprise of -21.31% [1] - The company generated revenues of $2.31 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 18.02%, and showing an increase from $1.39 million in the same quarter last year [2] - Nyxoah shares have declined approximately 26.4% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Financial Performance - Over the last four quarters, Nyxoah has only surpassed consensus EPS estimates once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.58 on revenues of $3.59 million, and for the current fiscal year, it is -$2.52 on revenues of $8.34 million [7] Market Outlook - The estimate revisions trend for Nyxoah was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell), suggesting expected underperformance in the near future [6] - The outlook for the Medical Info Systems industry, where Nyxoah operates, is currently in the top 30% of over 250 Zacks industries, indicating a favorable environment that could impact stock performance positively [8]

Group 1 - Evolv Technologies Holdings, Inc. reported a quarterly loss of $0.01 per share, better than the Zacks Consensus Estimate of a loss of $0.07, and an improvement from a loss of $0.19 per share a year ago, resulting in an earnings surprise of +85.71% [1] - The company achieved revenues of $42.85 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 27.25%, compared to $27.36 million in the same quarter last year [2] - Evolv Technologies shares have increased approximately 70.1% year-to-date, significantly outperforming the S&P 500's gain of 16.5% [3] Group 2 - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend of estimate revisions for Evolv Technologies was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] - Current consensus EPS estimate for the next quarter is -$0.07 on revenues of $35.34 million, and for the current fiscal year, it is -$0.40 on revenues of $133.62 million [7] Group 3 - The Computers - IT Services industry, to which Evolv Technologies belongs, is currently ranked in the top 25% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this sector [8]

Core Viewpoint - VistaGen Therapeutics reported a quarterly loss of $0.54 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.51, indicating a negative earnings surprise of -5.88% [1][2] Financial Performance - The company posted revenues of $0.26 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 59.05%, compared to revenues of $0.18 million a year ago [2] - Over the last four quarters, VistaGen has surpassed consensus EPS estimates two times but has not beaten consensus revenue estimates [2] Stock Performance - VistaGen shares have increased approximately 38% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] Future Outlook - The company's earnings outlook will be crucial for determining future stock movements, with current consensus EPS estimates at -$0.32 on $0.47 million in revenues for the coming quarter and -$1.56 on $0.95 million in revenues for the current fiscal year [4][7] - The estimate revisions trend for VistaGen was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Medical - Biomedical and Genetics industry, to which VistaGen belongs, is currently in the top 35% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% of industries [8]

Core Viewpoint - Sera Prognostics, Inc. reported a quarterly loss of $0.16 per share, which was better than the Zacks Consensus Estimate of a loss of $0.19, indicating an earnings surprise of +15.79% [1] Group 1: Earnings Performance - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - The quarterly revenue was $0.02 million, missing the Zacks Consensus Estimate by 75.39%, compared to $0.03 million in the same quarter last year [2] - The stock has lost approximately 61.7% since the beginning of the year, while the S&P 500 has gained 16.5% [3] Group 2: Future Outlook - The future performance of Sera Prognostics' stock will depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is -$0.19 on revenues of $0.1 million, and for the current fiscal year, it is -$0.73 on revenues of $0.12 million [7] Group 3: Industry Context - The Medical Services industry, to which Sera Prognostics belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, which may impact the stock's performance [8]

Group 1 - The article does not provide any specific content related to a company or industry [1]

Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday. ...

Core Insights - Viasat Inc. successfully executed its first flight test of a launch telemetry data relay service on Blue Origin's New Glenn rocket, marking a significant milestone in its partnership with NASA [1][3][6] - The demonstration is part of NASA's Communications Services Project, aimed at developing commercial satellite relay communications services to support future science missions as NASA phases out its Tracking and Data Relay Satellite fleet [2][5] Viasat's Launch Telemetry Data Relay Service - The HaloNet launch data relay solution provides continuous, real-time data transmission during launch operations, utilizing Viasat's global L-band satellite network and geostationary satellites [4][5] - During the initial demonstration, a persistent connection was established, allowing flight data to be transmitted to the launch operations center for processing [4][5] Future Plans and Collaborations - Viasat plans additional solution demonstrations as part of its partnership with NASA, with a second demonstration mission with Blue Origin anticipated for early next calendar year [5][6] - The company aims to validate how commercial technology can support both NASA and other launch providers in future missions [3][5]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - The CEO of FIS, Stephanie Ferris, has highlighted significant accomplishments over the past three years, including the separation from Worldpay and a strategic realignment for future growth [1][2] - The company is optimistic about its position in the fintech sector, emphasizing the foundational work done that will support advancements in technologies such as AI and tokenized deposits as it moves towards 2026 and beyond [2] Company Developments - FIS has successfully completed the separation from Worldpay, which is a major milestone for the company [1] - The company is focusing on infrastructure improvements and strategic initiatives that will enable it to leverage advanced technologies in the future [2] Industry Outlook - The fintech industry is experiencing a transformative period, with companies like FIS preparing to adopt scaled technologies that will enhance their service offerings [2] - There is a strong emphasis on innovation within the industry, particularly in areas such as artificial intelligence and digital financial solutions [2]